The 2024 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office will feature an impressive line-up of distinguished speakers, national and local investors, and numerous Utah life sciences startups.

On Thursday, March 14th, from 8:45 am-9:30 a.m., Wilson Sonsini partner Nathan Robinson will moderate a CEO Panel with Ciara Kennedy, President & CEO of Sorriso Pharmaceuticals; Myles Greenberg, President & CEO of Alucent Biomedical, Inc.; Clark Turner, CEO of Turner Med Tech and Fred Lampropoulos, CEO of Merit Medical Systems.

On Thursday, March 14th, from 9:30 – 10:15 a.m., Wilson Sonsini partner, Marc Porter will moderate the panel, State of Venture Capital in Life Sciences with Adele Olivia, Founding Partner of 1315 Capital; Jenny Barba, Co-Founder, Managing Partner, of Features Capital; Nate Chang, Operating Partner, Life Sciences, Playground VC, and speaker Witney McKiernan, Principal of HealthQuest Capital.

Now in its 10th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.